COLL · Collegium Pharmaceutical Inc. Common Stock
View on chartInsiders & Stakes
| Rubric Capital Management LP 10% Owner | ▼ Sell | Open Market | 3,132,743 Shares held | 8/13/2025 | View profile |
| Joseph Ciaffoni President and CEO | ▼ Sell | Tax Withholding | 444,867 Shares held | 2/12/2024 | View profile |
| Vikram Karnani President and CEO | ▼ Sell | Tax Withholding | 197,864 Shares held | 2/10/2026 | View profile |
| Colleen Tupper EVP & Chief Financial Officer | ▼ Sell | Tax Withholding | 147,282 Shares held | 2/10/2026 | View profile |
| Malamut Richard EVP and Chief Medical Officer | ▼ Sell | Tax Withholding | 130,264 Shares held | 2/10/2022 | View profile |
| Gino Santini Director | ▲ Buy | Option Exercise | 112,483 Shares held | 6/8/2026 | View profile |
| Kuhlmann Shirley R. EVP and General Counsel | ▼ Sell | Open Market | 108,137 Shares held | 3/6/2025 | View profile |
| Thomas B. Smith EVP and Chief Medical Officer | ▼ Sell | Tax Withholding | 90,651 Shares held | 2/10/2026 | View profile |
| John Gordon Freund Director | ▼ Sell | Open Market | 83,952 Shares held | 5/18/2026 | View profile |
| David Dieter EVP & General Counsel | ▼ Sell | Open Market | 77,071 Shares held | 3/18/2026 | View profile |
| Scott Dreyer EVP & Chief Commercial Officer | ▼ Sell | Open Market | 71,770 Shares held | 3/3/2026 | View profile |
| Garen G. Bohlin Director | ▲ Buy | Grant | 71,000 Shares held | 5/14/2026 | View profile |
| John A. Fallon Director | ▼ Sell | Open Market | 64,634 Shares held | 11/12/2025 | View profile |
| Rita J. Balice-Gordon Director | ▲ Buy | Grant | 61,370 Shares held | 5/14/2026 | View profile |
| Gwen A. Melincoff Director | ▲ Buy | Grant | 52,468 Shares held | 5/16/2024 | View profile |
| Heffernan Michael Thomas Director | ▲ Buy | Grant | 50,328 Shares held | 2/10/2025 | View profile |
| McFarlane Neil F. President and CEO | ▲ Buy | Grant | 49,365 Shares held | 5/16/2024 | View profile |
| Carlos Paya V Director | ▲ Buy | Grant | 28,323 Shares held | 5/14/2026 | View profile |
| Nancy Lurker Director | ▲ Buy | Grant | 26,758 Shares held | 5/14/2026 | View profile |
| Donovan Michael Glancy | ▲ Buy | Grant | 17,482 Shares held | 5/14/2026 | View profile |
Transaction History
| Gino Santini | ▲ Buy | Option Exercise | 8,700 | $143K | 6/8/2026 |
| John Gordon Freund | ▼ Sell | Open Market | 20 | $681 | 5/18/2026 |
| John Gordon Freund | ▲ Buy | Option Exercise | 8,700 | $143K | 5/15/2026 |
| John Gordon Freund | ▼ Sell | Open Market | 4,127 | $143K | 5/15/2026 |
| Nancy Lurker | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| Carlos Paya V | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| John Gordon Freund | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| Donovan Michael Glancy | ▲ Buy | Grant | 17,482 | $0 | 5/14/2026 |
| Garen G. Bohlin | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| Rita J. Balice-Gordon | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| Gino Santini | ▲ Buy | Grant | 8,741 | $0 | 5/14/2026 |
| Nancy Lurker | ▼ Sell | Open Market | 4,500 | $162K | 5/13/2026 |
| Garen G. Bohlin | ▲ Buy | Option Exercise | 8,700 | $143K | 5/11/2026 |
| Garen G. Bohlin | ▼ Sell | Open Market | 8,700 | $323K | 5/11/2026 |
| David Dieter | ▼ Sell | Open Market | 13,976 | $488K | 3/18/2026 |
| David Dieter | ▼ Sell | Tax Withholding | 8,840 | $316K | 3/17/2026 |
| David Dieter | ▼ Sell | Open Market | 6,224 | $228K | 3/9/2026 |
| Scott Dreyer | ▼ Sell | Open Market | 46,417 | $1.9M | 3/3/2026 |
| Scott Dreyer | ▼ Sell | Open Market | 3,559 | $146K | 3/3/2026 |
| David Dieter | ▲ Buy | Grant | 22,194 | $0 | 2/10/2026 |
| David Dieter | ▲ Buy | Grant | 9,005 | $0 | 2/10/2026 |
| David Dieter | ▼ Sell | Tax Withholding | 2,781 | $130K | 2/10/2026 |
| Vikram Karnani | ▲ Buy | Grant | 79,264 | $0 | 2/10/2026 |
| Vikram Karnani | ▲ Buy | Grant | 32,531 | $0 | 2/10/2026 |
| Vikram Karnani | ▼ Sell | Tax Withholding | 11,296 | $528K | 2/10/2026 |
| Thomas B. Smith | ▲ Buy | Grant | 14,268 | $0 | 2/10/2026 |
| Thomas B. Smith | ▲ Buy | Grant | 22,774 | $0 | 2/10/2026 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 5,897 | $276K | 2/10/2026 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 11,538 | $539K | 2/10/2026 |
| Colleen Tupper | ▲ Buy | Grant | 26,421 | $0 | 2/10/2026 |
| Colleen Tupper | ▲ Buy | Grant | 32,734 | $0 | 2/10/2026 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 11,861 | $555K | 2/10/2026 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 26,679 | $1.2M | 2/10/2026 |
| Scott Dreyer | ▲ Buy | Grant | 19,023 | $0 | 2/10/2026 |
| Scott Dreyer | ▲ Buy | Grant | 30,702 | $0 | 2/10/2026 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 9,977 | $466K | 2/10/2026 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 21,615 | $1.0M | 2/10/2026 |
| Scott Dreyer | ▲ Buy | Option Exercise | 17,600 | $280K | 12/8/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 11,125 | $533K | 12/8/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 6,475 | $315K | 12/8/2025 |
| Rita J. Balice-Gordon | ▼ Sell | Open Market | 3,650 | $172K | 12/5/2025 |
| Vikram Karnani | ▼ Sell | Tax Withholding | 8,983 | $425K | 11/12/2025 |
| John A. Fallon | ▲ Buy | Option Exercise | 15,000 | $247K | 11/12/2025 |
| John A. Fallon | ▲ Buy | Option Exercise | 19,853 | $185K | 11/12/2025 |
| John A. Fallon | ▼ Sell | Open Market | 34,853 | $1.6M | 11/12/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 25,142 | $1.0M | 11/6/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 4,858 | $201K | 11/6/2025 |
| Thomas B. Smith | ▼ Sell | Open Market | 17,478 | $672K | 8/29/2025 |
| Scott Dreyer | ▲ Buy | Option Exercise | 16,389 | $350K | 8/18/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 16,389 | $626K | 8/18/2025 |
| Gino Santini | ▲ Buy | Option Exercise | 15,000 | $202K | 8/15/2025 |
| Gino Santini | ▼ Sell | Open Market | 5,405 | $201K | 8/15/2025 |
| Scott Dreyer | ▲ Buy | Option Exercise | 4,861 | $104K | 8/13/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 4,861 | $185K | 8/13/2025 |
| Rubric Capital Management LP | ▼ Sell | Open Market | 25,000 | $946K | 8/13/2025 |
| John Gordon Freund | ▼ Sell | Open Market | 11,659 | $401K | 8/8/2025 |
| John Gordon Freund | ▲ Buy | Option Exercise | 15,000 | $202K | 6/9/2025 |
| John Gordon Freund | ▼ Sell | Open Market | 6,601 | $202K | 6/9/2025 |
| Nancy Lurker | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| John A. Fallon | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| Garen G. Bohlin | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| Rita J. Balice-Gordon | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| John Gordon Freund | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| Gino Santini | ▲ Buy | Grant | 9,791 | $0 | 5/15/2025 |
| Carlos Paya V | ▲ Buy | Grant | 19,582 | $0 | 5/15/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 6,396 | $192K | 3/21/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 18,881 | $567K | 3/21/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 1,206 | $36K | 3/20/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 1,927 | $58K | 3/20/2025 |
| David Dieter | ▲ Buy | Grant | 68,449 | $0 | 3/17/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 977 | $29K | 3/14/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 2,255 | $68K | 3/14/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 10,445 | $313K | 3/11/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 1,504 | $45K | 3/7/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 2,348 | $70K | 3/7/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 15,387 | $462K | 3/6/2025 |
| Colleen Tupper | ▼ Sell | Open Market | 1,949 | $58K | 3/6/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 26,067 | $743K | 3/6/2025 |
| Scott Dreyer | ▼ Sell | Open Market | 3,295 | $99K | 3/6/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 20,000 | $561K | 3/5/2025 |
| Kuhlmann Shirley R. | ▲ Buy | Option Exercise | 40,000 | $961K | 3/4/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 40,000 | $1.1M | 3/4/2025 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 1,498 | $46K | 2/10/2025 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 4,399 | $134K | 2/10/2025 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 7,953 | $243K | 2/10/2025 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 21,670 | $661K | 2/10/2025 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 8,109 | $247K | 2/10/2025 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 22,317 | $681K | 2/10/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 9,826 | $300K | 2/10/2025 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 29,030 | $0 | 2/10/2025 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 40,965 | $0 | 2/10/2025 |
| Colleen Tupper | ▲ Buy | Grant | 26,957 | $0 | 2/10/2025 |
| Scott Dreyer | ▲ Buy | Grant | 26,411 | $0 | 2/10/2025 |
| Scott Dreyer | ▲ Buy | Grant | 45,016 | $0 | 2/10/2025 |
| Thomas B. Smith | ▲ Buy | Grant | 33,762 | $0 | 2/10/2025 |
| Thomas B. Smith | ▲ Buy | Grant | 5,313 | $0 | 2/10/2025 |
| Heffernan Michael Thomas | ▲ Buy | Grant | 4,820 | $0 | 2/10/2025 |
| Colleen Tupper | ▲ Buy | Grant | 51,768 | $0 | 2/10/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 25,149 | $768K | 2/10/2025 |
| Nancy Lurker | ▲ Buy | Grant | 12,726 | $0 | 2/4/2025 |
| Kuhlmann Shirley R. | ▲ Buy | Option Exercise | 27,500 | $587K | 1/10/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 21,400 | $703K | 1/10/2025 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 6,100 | $205K | 1/10/2025 |
| Vikram Karnani | ▲ Buy | Grant | 105,972 | $0 | 11/12/2024 |
| Thomas B. Smith | ▼ Sell | Open Market | 9,593 | $351K | 9/13/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 977 | $37K | 9/6/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 16,848 | $643K | 9/5/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 2,400 | $94K | 9/5/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 700 | $23K | 6/3/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 24,300 | $791K | 6/3/2024 |
| Colleen Tupper | ▼ Sell | Open Market | 19,710 | $674K | 5/28/2024 |
| Scott Dreyer | ▲ Buy | Option Exercise | 23,791 | $572K | 5/24/2024 |
| Scott Dreyer | ▼ Sell | Open Market | 56,807 | $1.9M | 5/24/2024 |
| Scott Dreyer | ▲ Buy | Option Exercise | 51,209 | $1.2M | 5/23/2024 |
| Scott Dreyer | ▼ Sell | Open Market | 51,209 | $1.7M | 5/23/2024 |
| John Gordon Freund | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Garen G. Bohlin | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| McFarlane Neil F. | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Heffernan Michael Thomas | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| John A. Fallon | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Rita J. Balice-Gordon | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Gino Santini | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Gwen A. Melincoff | ▲ Buy | Grant | 7,693 | $0 | 5/16/2024 |
| Garen G. Bohlin | ▲ Buy | Option Exercise | 28,985 | $166K | 5/14/2024 |
| Garen G. Bohlin | ▼ Sell | Open Market | 28,985 | $936K | 5/14/2024 |
| Thomas B. Smith | ▼ Sell | Open Market | 995 | $37K | 2/29/2024 |
| Scott Dreyer | ▼ Sell | Open Market | 9,336 | $340K | 2/26/2024 |
| Scott Dreyer | ▼ Sell | Open Market | 664 | $25K | 2/26/2024 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 16,868 | $568K | 2/12/2024 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 9,453 | $319K | 2/12/2024 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 19,545 | $659K | 2/12/2024 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 10,145 | $342K | 2/12/2024 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 1,899 | $64K | 2/12/2024 |
| Thomas B. Smith | ▼ Sell | Tax Withholding | 1,300 | $44K | 2/12/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 21,146 | $713K | 2/12/2024 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 10,610 | $358K | 2/12/2024 |
| Colleen Tupper | ▲ Buy | Grant | 40,600 | $0 | 2/12/2024 |
| Colleen Tupper | ▲ Buy | Grant | 30,856 | $0 | 2/12/2024 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 33,247 | $0 | 2/12/2024 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 43,400 | $0 | 2/12/2024 |
| Thomas B. Smith | ▲ Buy | Grant | 4,623 | $0 | 2/12/2024 |
| Joseph Ciaffoni | ▲ Buy | Grant | 119,000 | $0 | 2/12/2024 |
| Scott Dreyer | ▲ Buy | Grant | 32,286 | $0 | 2/12/2024 |
| Joseph Ciaffoni | ▲ Buy | Grant | 179,734 | $0 | 2/12/2024 |
| Thomas B. Smith | ▲ Buy | Grant | 30,800 | $0 | 2/12/2024 |
| Scott Dreyer | ▲ Buy | Grant | 35,000 | $0 | 2/12/2024 |
| Joseph Ciaffoni | ▼ Sell | Tax Withholding | 47,445 | $1.6M | 2/12/2024 |
| Joseph Ciaffoni | ▼ Sell | Tax Withholding | 81,422 | $2.7M | 2/12/2024 |
| Scott Dreyer | ▼ Sell | Open Market | 23,560 | $761K | 1/16/2024 |
| Joseph Ciaffoni | ▲ Buy | Option Exercise | 4,357 | $93K | 12/21/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 4,357 | $132K | 12/21/2023 |
| Joseph Ciaffoni | ▲ Buy | Option Exercise | 26,454 | $565K | 12/20/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 26,454 | $804K | 12/20/2023 |
| Joseph Ciaffoni | ▲ Buy | Option Exercise | 14,516 | $310K | 12/19/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 14,516 | $436K | 12/19/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 27,798 | $835K | 12/18/2023 |
| Joseph Ciaffoni | ▲ Buy | Option Exercise | 27,798 | $593K | 12/18/2023 |
| Kuhlmann Shirley R. | ▲ Buy | Option Exercise | 25,600 | $407K | 11/27/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 25,600 | $660K | 11/27/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 16,621 | $360K | 6/26/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 1,363 | $31K | 6/26/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 30,272 | $653K | 6/2/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 1,000 | $22K | 6/2/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 31,272 | $691K | 6/1/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 31,272 | $684K | 5/31/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 31,271 | $685K | 5/30/2023 |
| Gino Santini | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| Gwen A. Melincoff | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| John A. Fallon | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| Garen G. Bohlin | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| John Gordon Freund | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| Heffernan Michael Thomas | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| McFarlane Neil F. | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| Rita J. Balice-Gordon | ▲ Buy | Grant | 9,792 | $0 | 5/18/2023 |
| Colleen Tupper | ▼ Sell | Open Market | 31,640 | $752K | 3/15/2023 |
| Scott Dreyer | ▼ Sell | Open Market | 13,324 | $356K | 3/1/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Open Market | 21,811 | $586K | 2/13/2023 |
| Joseph Ciaffoni | ▲ Buy | Option Exercise | 11,250 | $179K | 2/13/2023 |
| Joseph Ciaffoni | ▼ Sell | Open Market | 11,250 | $302K | 2/13/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 16,291 | $436K | 2/10/2023 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 3,887 | $104K | 2/10/2023 |
| Joseph Ciaffoni | ▼ Sell | Tax Withholding | 59,736 | $1.6M | 2/10/2023 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 14,529 | $389K | 2/10/2023 |
| Scott Dreyer | ▼ Sell | Tax Withholding | 6,797 | $182K | 2/10/2023 |
| Joseph Ciaffoni | ▼ Sell | Tax Withholding | 44,121 | $1.2M | 2/10/2023 |
| Joseph Ciaffoni | ▲ Buy | Grant | 117,500 | $0 | 2/10/2023 |
| Scott Dreyer | ▲ Buy | Grant | 22,459 | — | 2/10/2023 |
| Scott Dreyer | ▲ Buy | Grant | 44,275 | $0 | 2/10/2023 |
| Thomas B. Smith | ▲ Buy | Grant | 31,185 | $0 | 2/10/2023 |
| Kuhlmann Shirley R. | ▼ Sell | Tax Withholding | 7,755 | $207K | 2/10/2023 |
| Colleen Tupper | ▼ Sell | Tax Withholding | 6,967 | $186K | 2/10/2023 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 25,739 | — | 2/10/2023 |
| Kuhlmann Shirley R. | ▲ Buy | Grant | 48,125 | $0 | 2/10/2023 |
| Joseph Ciaffoni | ▲ Buy | Grant | 137,694 | — | 2/10/2023 |
| Colleen Tupper | ▲ Buy | Grant | 12,565 | — | 2/10/2023 |
| Colleen Tupper | ▲ Buy | Grant | 45,045 | $0 | 2/10/2023 |
| Scott Dreyer | ▼ Sell | Open Market | 7,341 | $204K | 1/9/2023 |
| Scott Dreyer | ▼ Sell | Open Market | 69 | $2K | 1/9/2023 |
| Scott Dreyer | ▼ Sell | Open Market | 10,424 | $282K | 1/9/2023 |
| Heffernan Michael Thomas | ▲ Buy | Option Exercise | 15,995 | $258K | 12/27/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
COLL Outlook Supported by ADHD Trends, Low Generic Risk, Oppenheimer
Oppenheimer notes that Collegium Pharmaceutical's outlook is bolstered by strong demand for ADHD treatments and a low risk of generic competition. The firm’s focus on these areas may help sustain revenue growth. The stock is currently trading near its 52‑week low of $21.43, close to a support level that has been tested repeatedly.
COLL Outlook Supported by ADHD Trends, Low Generic Risk, Oppenheimer. Oppenheimer notes that Collegium Pharmaceutical's outlook is bolstered by strong demand for ADHD treatments and a low risk of generic competition. The firm’s focus on these areas may help sustain revenue growth. The stock is currently trading near its 52‑week low of $21.43, close to a support level that has been tested repeatedly.